Activation Markers CD63 and CD203c Are Upregulated in Chronic Urticaria
Claus Uhrenholt Christensen 1, 2 , Christian Vestergaard 1, 3 , Hans Jürgen Hoffmann Fig. 1 ). There was no difference in the expression of FceRI or CD123. It is possible to set thresholds to classify patients as likely to have urticaria on the basis of blood basophil concentration of 431 cells/4 minutes, basal CD63 median fluorescence intensity (MFI)＞1,636 and CD203c MFI＞ 2,160 with area under the curve of 0.92, 0.88 and 0.90, respectively. Our findings correlate with the findings of Lourenço et al. 4 regarding the basopenia of CU-patients and upregulation of CD63 and CD203c; however, we did not find an increase in FcεRIα-expression. In a similar study on enriched basophil suspensions, CD203c expression was not found to be up-regulated with urticarial subjects 7 . This may be because even a partial purification of basophils can profoundly limit the basophil function 8 .
With our small dataset, it was not possible to determine a correlation of high expression of activation markers CD63 and CD203c with positive HR. The patients in our study were seen on an out-patient basis and thus, it is not possible to conclude from our study for how long the baseline activation markers are raised. Further investigations into baseline basophils activation markers in direct timely relation to disease outburst and attack are needed. Our study does however contribute with evidence of the activated profile of basophils in CU. We confirm that a flow cytometric analysis of basophil concentration as well as basal expression of CD63 and CD203c in patient blood may be used to diagnose patients with CU. This may then be investigated for the involvement of autoantibodies by a basophil activation test. Further studies are needed to investigate if CD63 and CD203c may be used to monitor the efficacy of treatment. Furthermore, our findings indicate that the activation of basophils may be an important event in the pathogenesis of CU.
